Skip to main content
Erschienen in: Cancer Causes & Control 1/2018

02.12.2017 | Original paper

Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence

verfasst von: NaNa Keum, Kyoung Hwa Ha, Ying Bao, Moon Jae Chung, Hyeon Chang Kim, Edward L. Giovannucci

Erschienen in: Cancer Causes & Control | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Whether type 2 diabetes is cause or consequence, or both, of pancreatic cancer (PaC) remains unresolved. Leveraging repeated measurements of fasting blood glucose (FBG), we examined the temporal relationship between hyperglycemia and PaC incidence.

Methods

We conducted a nested case–control study of 278 cases and 826 matched-controls from the Korean National Health Insurance Service-Health Screening Cohort. Over 11 years before index date (date of PaC diagnosis for cases), all participants had at least one FBG measurement in each of the three time windows: − 11 to − 8, − 7 to − 4, and − 3 to 0 years. Using conditional logistic regression, we estimated odds ratios(ORs) of PaC and 95% confidence intervals (CIs) for hyperglycemia in the overall period and at each interval; for major long-term patterns of FBG across the three intervals (recent-onset, medium-term, and long-standing hyperglycemia).

Results

Higher FBG over the past 11 years was associated with an increased odds of PaC (p trend < .0001), with recent FBG more predictive of PaC than distant FBG. By FBG assessed in the − 3 to 0 interval, OR was 1.97 (95% CI 1.32–2.93) for 110–125 mg/dL and 3.17 (95% CI 2.09–4.80) for ≥ 126 mg/dL. By long-term patterns of FBG, compared to consistent normoglycemia, OR was 2.02 (95% CI 1.24–3.31) for long-standing hyperglycemia and 3.38 (95% CI 1.87–6.13) for recent-onset hyperglycemia. These associations were more pronounced among never-smokers than ever-smokers (p interaction = .06).

Conclusion

Recent-onset hyperglycemia may be an early manifestation of undetected PaC, while long-lasting hyperglycemia may serve as a moderate etiologic factor for PaC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
4.
Zurück zum Zitat Yachida S, Iacobuzio-Donahue CA (2013) Evolution and dynamics of pancreatic cancer progression. Oncogene 32:5253–5260CrossRefPubMed Yachida S, Iacobuzio-Donahue CA (2013) Evolution and dynamics of pancreatic cancer progression. Oncogene 32:5253–5260CrossRefPubMed
5.
6.
Zurück zum Zitat Pannala R, Basu A, Petersen GM, Chari ST (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10:88–95CrossRefPubMedPubMedCentral Pannala R, Basu A, Petersen GM, Chari ST (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10:88–95CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Han L, Ma Q, Li J et al (2011) High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS ONE 6:e27074CrossRefPubMedPubMedCentral Han L, Ma Q, Li J et al (2011) High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS ONE 6:e27074CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Sah RP, Nagpal SJS, Mukhopadhyay D, Chari ST. (2013) New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastrol Hepatol 10:423–433CrossRef Sah RP, Nagpal SJS, Mukhopadhyay D, Chari ST. (2013) New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastrol Hepatol 10:423–433CrossRef
10.
Zurück zum Zitat Pang JX, Hsu JP, Yeo TW, Leo YS, Lye DC (2017) Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: a matched case–control study. Sci Rep 7:39872CrossRefPubMedPubMedCentral Pang JX, Hsu JP, Yeo TW, Leo YS, Lye DC (2017) Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: a matched case–control study. Sci Rep 7:39872CrossRefPubMedPubMedCentral
11.
12.
Zurück zum Zitat Chari ST, Leibson CL, Rabe KG et al (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134:95–101CrossRefPubMed Chari ST, Leibson CL, Rabe KG et al (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134:95–101CrossRefPubMed
13.
Zurück zum Zitat Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 43:1130–1139CrossRefPubMed Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 43:1130–1139CrossRefPubMed
14.
Zurück zum Zitat American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69CrossRefPubMedCentral American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69CrossRefPubMedCentral
15.
Zurück zum Zitat Ardisson Korat AV, Willett WC, Hu FB (2014) Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the Nurses’ Health Study, Nurses’ Health Study 2, and Health Professionals’ follow-up study. Curr Nutr Rep 3:345–354CrossRefPubMedPubMedCentral Ardisson Korat AV, Willett WC, Hu FB (2014) Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the Nurses’ Health Study, Nurses’ Health Study 2, and Health Professionals’ follow-up study. Curr Nutr Rep 3:345–354CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kahn SE, Prigeon RL, Schwartz RS et al (2001) Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr 131:354S–360SPubMed Kahn SE, Prigeon RL, Schwartz RS et al (2001) Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr 131:354S–360SPubMed
17.
Zurück zum Zitat Lim U, Ernst T, Buchthal SD et al (2011) Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes 1:e6CrossRefPubMedPubMedCentral Lim U, Ernst T, Buchthal SD et al (2011) Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes 1:e6CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Liao WC, Tu YK, Wu MS, Lin JT, Wang HP, Chien KL. (2015) Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ-Brit Med J 349:g7371CrossRef Liao WC, Tu YK, Wu MS, Lin JT, Wang HP, Chien KL. (2015) Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ-Brit Med J 349:g7371CrossRef
20.
Zurück zum Zitat Ramlo-Halsted BA, Edelman SV (1999) The natural history of type 2 diabetes: implications for clinical practice. Primary Care 26:771–789CrossRefPubMed Ramlo-Halsted BA, Edelman SV (1999) The natural history of type 2 diabetes: implications for clinical practice. Primary Care 26:771–789CrossRefPubMed
21.
Zurück zum Zitat Wolpin BM, Bao Y, Qian ZR et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic -cell function, and risk of pancreatic cancer. JNCI-J Natl Cancer Inst 105:1027–1035CrossRef Wolpin BM, Bao Y, Qian ZR et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic -cell function, and risk of pancreatic cancer. JNCI-J Natl Cancer Inst 105:1027–1035CrossRef
22.
Zurück zum Zitat Mayers JR, Wu C, Clish CB et al (2014) Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med 20:1193–1198CrossRefPubMedPubMedCentral Mayers JR, Wu C, Clish CB et al (2014) Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med 20:1193–1198CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Cohen R, Neuzillet C, Tijeras-Raballand A, Faivre S, de Gramont A, Raymond E (2015) Targeting cancer cell metabolism in pancreatic adenocarcinoma. Oncotarget 6:16832–16847CrossRefPubMedPubMedCentral Cohen R, Neuzillet C, Tijeras-Raballand A, Faivre S, de Gramont A, Raymond E (2015) Targeting cancer cell metabolism in pancreatic adenocarcinoma. Oncotarget 6:16832–16847CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Sinacore DR, Gulve EA. (1993) The role of skeletal muscle in glucose transport, glucose homeostasis, and insulin resistance: implications for physical therapy. Phys Ther 73:878–891CrossRefPubMed Sinacore DR, Gulve EA. (1993) The role of skeletal muscle in glucose transport, glucose homeostasis, and insulin resistance: implications for physical therapy. Phys Ther 73:878–891CrossRefPubMed
27.
Zurück zum Zitat Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961–969CrossRefPubMed Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961–969CrossRefPubMed
28.
Zurück zum Zitat Hu Y, Bhupathiraju SN, de Koning L, Hu FB (2014) Duration of obesity and overweight and risk of type 2 diabetes among US women. Obesity 22:2267–2273CrossRefPubMedPubMedCentral Hu Y, Bhupathiraju SN, de Koning L, Hu FB (2014) Duration of obesity and overweight and risk of type 2 diabetes among US women. Obesity 22:2267–2273CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB (2001) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161:1542–1548CrossRefPubMed Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB (2001) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161:1542–1548CrossRefPubMed
30.
Zurück zum Zitat Grontved A, Pan A, Mekary RA et al (2014) Muscle-strengthening and conditioning activities and risk of type 2 diabetes: a prospective study in two cohorts of US women. PLoS Med 11:e1001587CrossRefPubMedPubMedCentral Grontved A, Pan A, Mekary RA et al (2014) Muscle-strengthening and conditioning activities and risk of type 2 diabetes: a prospective study in two cohorts of US women. PLoS Med 11:e1001587CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Munigala S, Singh A, Gelrud A, Agarwal B (2015) Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus. Clin Transl Gastroenterol 6:e118CrossRefPubMedPubMedCentral Munigala S, Singh A, Gelrud A, Agarwal B (2015) Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus. Clin Transl Gastroenterol 6:e118CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Davidson MB, Schriger DL, Peters AL, Lorber B (1999) Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281:1203–1210CrossRefPubMed Davidson MB, Schriger DL, Peters AL, Lorber B (1999) Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281:1203–1210CrossRefPubMed
33.
Zurück zum Zitat Pang Y, Kartsonaki C, Guo Y et al. (2017) Diabetes, plasma glucose and incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies. Int J Cancer 140:1781CrossRefPubMedPubMedCentral Pang Y, Kartsonaki C, Guo Y et al. (2017) Diabetes, plasma glucose and incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies. Int J Cancer 140:1781CrossRefPubMedPubMedCentral
Metadaten
Titel
Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence
verfasst von
NaNa Keum
Kyoung Hwa Ha
Ying Bao
Moon Jae Chung
Hyeon Chang Kim
Edward L. Giovannucci
Publikationsdatum
02.12.2017
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 1/2018
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-017-0988-6

Weitere Artikel der Ausgabe 1/2018

Cancer Causes & Control 1/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.